期刊文献+

针对HO-2基因的四种RNA干扰序列构建和效应观察

Construction and identification of four RNA interference vectors targeting on HO-2 gene
下载PDF
导出
摘要 目的:构建和筛选出血红素氧合酶-2(HO-2)基因的RNA干扰载体,并观察其在小鼠脑血管内皮细胞中的表达情况。方法:根据小鼠HO-2基因的c DNA序列设计了4个HO-2基因干扰序列,克隆到干扰载体p GPU6-GFP-Neo上,利用电穿孔法将干扰载体对小鼠脑血管内皮细胞进行转染。Real-time PCR和Western Blot检测小鼠脑血管内皮细胞中HO-2的表达。结果:干扰载体显著抑制小鼠脑血管内皮细胞中HO-2的表达,其中干扰载体p GPU6-GFP-Neo-HO-2-mus-768对HO-2 mRNA的表达抑制达显著水平(P<0.01),蛋白的表达抑制达显著水平(P<0.05)。结论:成功构建并筛选了HO-2表达干扰载体,为下一步的HO-2基因的功能鉴定奠定了基础。 Objective: To construct heme oxygenase-2 interference vectors,and observe their expression in cerebrovascular endothelial cells of mice. Methods: Four interference sequences were designed according to the the c DNA sequence of HO-2 gene,which were cloned into interference vector p GPU6-GFP-Neo. Then cerebrovascular endothelial cells were transfected with the interference vector using electroporation,the Real-time PCR and Western Blot was used to detect HO-2 mRNA and protein levels in cerebrovascular endothelial cells. Results: The interference vectors highly suppressed the HO-2 gene expression of cerebrovascular endothelial cells,and the interference vector p GPU6-GFP-Neo-HO-2-mus-768 extremely significant suppressed the mRNA expression of HO-2( P 〈 0. 01),and the protein expression inhibition also reached significant level( P 〈 0. 05). Conclusion: The interference vector p GPU6-GFP-Neo-HO-2 was successfully constructed and selected,which may be benefit for further study the mechanisms and function of HO-2 gene.
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2015年第2期161-164,共4页 Chinese Journal of Neuroanatomy
基金 国家自然科学基金(31172171) 江苏省青年基金(BK2012138) 徐州医学院院长基金(2012KJZ20)
关键词 HO-2基因 RNA干扰载体 基因表达 大鼠 HO-2 gene RNA interference vector gene expression mouse
  • 相关文献

参考文献19

  • 1Sodhi K, Inoue K, Gotlinger KH, et al. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice [J]. J Pharmaeol Exp Ther, 2009, 331:906-916.
  • 2Seta F, Bellner L, Rezzani R, et al. Heine oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response [ J]. Am J Pathol, 2006, 169:1612 - 1623.
  • 3Kikuehi G, Yoshida T, Noguehi M. Heme oxygenase and heine degradation [ J]. Bioehem Biophys Res Commun, 2005, 338:558 -670.
  • 4Vukomanovie D, Rahman MN, Bilokin Y, et al. In vitro Activation of heme oxygenase-2 by menadione and its analogs [ J ]. Med Gas Res, 2014, 4: 4.
  • 5Vukomanovic D, McLaughlin BE, Rahman MN, et al. Selective ac- tivation of heme oxygenase-2 by menadione [ J ]. Can J Physiol Phannacol, 2011, 89:861 - 886.
  • 6Parfenova H, Neff RA 3rd, Alonso JS, et al. Cerebral vascular en- dothelial heme oxygenase : expression, localization, and activation by glutamate [J]. Am J Physiol Cell Physiol, 2001,281: C1954- G1963.
  • 7Carratu P, Pourcyrous M, Fedinec A, et al. Endogenous heme oxy-genase prevents impairment of cerebral vascular functions caused by seizures [ J ]. Am J Physiol Heart Circ Physiol, 2003, 285: H1 148-H1157.
  • 8VaneUa L, Li Volti G, Guceione S, et al. Heine oxygenase-2/adi- poneetin protein-protein interaction in metabolic syndrome [ J ]. Biochem Biophys Res Commun, 2013, 432:606 -611.
  • 9Basuroy S, Bhattaeharya S, Teheranova D. 140-2 provides endoge- nous protection against oxidative stress and apoptosis eansed by TNF-a in cerebral vascular endothelial cells [ J ]. Am J Physiol Cell Physiol, 2006, 291: C897-C908.
  • 10Carratu P, Pouteyrous M, Fedinec A, et al. Endogenous heine oxy- genase prevents impairment of cerebral vascular functions caused by seizures [ J ] . Am J Physiol Heart Cite Physiol, 2003, 285: HI 148-H1157.

二级参考文献67

  • 1程国梅,石一复,周怀君,崔金全,牛战琴.妊娠高血压综合征患者胎盘组织中血红素氧合酶蛋白表达及其意义[J].中华妇产科杂志,2004,39(6):361-364. 被引量:11
  • 2王文珊,傅冷西,叶君健.TNF-α信号传导通路的研究进展[J].福建医科大学学报,2005,39(B08):27-31. 被引量:50
  • 3朱青山.草酸铂联合TNF腹腔内注射治疗胃肠道肿瘤所致腹水[J].现代医药卫生,2006,22(6):800-801. 被引量:7
  • 4马可,许兵,刘少华,徐鑫荣.一氧化碳保护大鼠肠道对抗LPS的作用机制[J].中国病理生理杂志,2007,23(7):1335-1338. 被引量:2
  • 5Eggermont AM,Schraffordt KH,Klausner JM,et al.Isolated limb perfusion with tumor necrosis factor andmelphalan for limb salvage in 186 patients with locallyadvanced soft tissue extremity sarcomas.Ann Surg,1996,224(6):756-64.
  • 6Van HR,Ten HTL,Eggermont AM.TNF-αin cancertreatment:molecular insights,antitumor effects,andclinical utility.Oncologist,2006,11(4):397-408.
  • 7Koss M,Pfeiffer GR,Wang Y,et al.Ezrin/radixin/moesinproteins are phosphorylated by TNF-αand modulatepermeability increases in human pulmonary microvascularendothelial cells.J Immunol,2006,176(2):1218-27.
  • 8Zhang W,Chen Z,LI F,et al.Tumour necrosis factor-α(TNF-α)trans-gene-express-ing dendritic cells(DCs)undergo augmented cellular maturation and induce morerobust T-cell activation and anti-tumour immunity thanDCs generated in recombinant TNF-α.Immunology,2003,108(2):177-88.
  • 9Moritz T,Niederle N,Baumann J,et al.Phase I study ofrecombinant human tumor necrosis factorαin advancedmalignant disease.Cancer Immunol Immunother,1989,29(2):144-50.
  • 10Lenk H,Tanneberger S,Muller U,et al.Phase II clinicaltrial of high-dose recombinant human tumor necrosisfactor.Cancer Chemother Pharmacol,1989,24(6):391-2.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部